Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity. Review uri icon

Overview

abstract

  • Naltrexone-bupropion is a recently approved drug combination for chronic weight management. In this article, we discuss the rationale for its use as a combination followed by a comprehensive review of safety and efficacy data from major preclinical, phase II and III clinical trials.

publication date

  • October 29, 2015

Research

keywords

  • Anti-Obesity Agents
  • Bupropion
  • Naltrexone
  • Obesity

Identity

Scopus Document Identifier

  • 84949100426

Digital Object Identifier (DOI)

  • 10.1586/17512433.2016.1100072

PubMed ID

  • 26512740

Additional Document Info

volume

  • 9

issue

  • 1